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Introduction
Mitochondrial DNA (mtDNA) mutations are known to be associated with a wide spectrum of human diseases whose unifying characteristic is the impairment of mitochondrial function (1, 2) . Over 150 pathogenic mutations have been reported so far, more than half of which are located within mitochondrial (mt) tRNA genes (2) . These mutations confer a variety of structural and functional defects that affect tRNAs at the post-transcriptional level, by impairing their maturation, modification, folding, aminoacylation, or association with translation factors (3, 4) . Among these defects, those which impair post-transcriptional modification have been the subject of particular attention in recent years (5, 6) .
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), a major clinical subgroup of the mitochondrial encephalomyopathies, is caused by any of several different single base replacements in the mt tRNA Leu(UUR) gene, which is responsible for the translation of UUR (R=A or G) leucine codons in mitochondrial gene ( Figure 1A ) (7) (8) (9) . We previously showed that in cybrid cells carrying homoplasmic MELAS-causing mutations in mtDNA, the taurine-containing modified uridine (τm 5 U;
5-taurinomethyluridine) (10) that is normally found at the anticodon first (wobble) position of mt tRNA Leu(UUR) remains unmodified in mutant mt tRNA Leu(UUR) molecules bearing either the A3243G or T3271C mutation (11) . More recently, we reported that mutant mt tRNAs Leu(UUR) bearing one of five different point mutations (A3243G, G3244A, T3258C, T3271C or T3291C), as have been found in tissues from patients with MELAS symptoms, lack τm 5 U modification (12) . In contrast, mt tRNAs Leu(UUR) , bearing different point mutations found in patients that have mitochondrial diseases lacking the defining features of MELAS syndrome, had the normal τm 5 U modification (12) . These results illustrate a clear correlation between the absence of wobble modification and the phenotypic features of MELAS. As modification of wobble uridines in tRNAs is responsible for specific and efficient codon recognition (13) (14) (15) , the presence of the unmodified uridine in the mutant mt tRNA Leu(UUR) is expected to induce a significant decoding disorder. Indeed, we previously demonstrated that an artificial mt tRNA Leu(UUR) of the wild-type sequence, including all modified bases except for τm 5 U at the wobble position, was severely defective in decoding UUG but not UUA codons (16) . This result clearly indicates that the taurine-modification at the wobble position in mt tRNA Leu(UUR) plays a crucial role in UUG decoding, presumably by stabilizing the U:G wobble base pairing. The UUG codon-specific translational defect caused by the wobble modification deficiency is thought to play a primary role in the molecular pathogenesis of
MELAS.
In a separate study, we (17) isolated a phenotypically revertant, A549 lung carcinoma cybrid cell line bearing >99% MELAS A3243G mutant mtDNA, but with normal respiratory activity. This line was found to harbour a second, heteroplasmic mutation, G12300A, in the anticodon sequence of mt tRNA Leu(CUN) gene, which is the other leucine isoacceptor tRNA responsible for decoding CUN (N=any base) codons. The severe impairment of both mitochondrial translation and respiratory activity in the A3243G cybrid was suppressed by the heteroplasmic mt tRNA Leu(CUN) mutation across a wide variety of heteroplasmy levels for G12300A (18) . The wild-type mt tRNA Leu(CUN) has an unmodified uridine at its wobble position, which allows all four CUN codons to be decoded in accord with the mitochondrial four-way wobble rule (19) . The G12300A mutation converts the anticodon sequence of mt tRNA Leu(CUN) from UAG to UAA, which is identical to that of mt tRNA Leu(UUR) , suggesting that the suppressor mt tRNA Leu(CUN) with the UAA anticodon could potentially translate UUR codons and thereby rescue the decoding disorder conferred by the MELAS mutation. However, given our finding that the MELAS mutant mt tRNA Leu(UUR) with an unmodified wobble uridine is incapable of translating UUG codons (16) .
In order to determine how MELAS A3243G cybrid cells with the suppressor G12300A mutation can revert to a wild-type phenotype at the molecular level, we undertook a detailed mass spectrometric analysis of the suppressor mt tRNA Leu(CUN) with the G12300A mutation isolated from revertant cells, and performed a functional analysis of its decoding properties. (21) and liquid chromatography / mass spectrometric (LC/MS) techniques (22, 23) . As shown in To analyze the suppressor mt tRNA Leu(CUN) possessing the G12300A mutation, a lung carcinoma cybrid cell line, G T61 , in which approximately 61% of the mtDNA has the G12300A mutation and 99% has the A3243G mutation (18) , was used. Suppressor mt tRNA Leu(CUN) carrying the G12300A mutation was isolated from G T61 cybrid cells by utilizing an improved solid-phase DNA probe method (10, 22) (Figure 2A ). After purification by gel electrophoresis, the suppressor tRNA and control wild-type mt leucine tRNAs were then subjected to nucleoside analysis by LC/MS using ESI/ion trap mass spectrometry. As shown in the mass chromatograms in Figure 2B , τm 5 U at the wobble position in mt tRNA Leu(UUR) purified from human placenta was detected as a positive ion with m/z 382, whereas τm 5 U
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was not detected in wild-type mt tRNA Leu(CUN) . A low level of τm 5 U was clearly detected in suppressor tRNA purified from G T61 cells ( Figure 2B ). The mass spectrum for a proton adduct form of τm 5 U is shown in Figure 2C . Judging from the areas of the peaks corresponding to τm 5 U on the mass chromatograms ( Figure 2B ), 29% of the suppressor tRNA contains the τm 5 U modification. Considering the extent of heteroplasmy of mtDNA in the G T61 cybrids (39% of mtDNA has G12300 and 61% has A12300), this result suggests that there are three species of mt tRNA Leu(CUN) in G T61 cell mitochondria: 39% is wild-type mt tRNA Leu(CUN) with an unmodified wobble uridine, 32% is suppressor mt tRNA Leu(CUN) with an unmodified wobble uridine, and 29% is suppressor mt tRNA Leu(CUN) with the τm 5 U modification.
The isolated suppressor tRNA was digested by RNase CL 3 (specific to C) and subjected to RNA fragment analysis by LC/MS. Figure 2D shows mass chromatograms of the anticodon-containing RNA fragments spanning from U33 to C38 produced by RNase CL 3 digestion of the wild-type and the suppressor mt tRNAs Leu(CUN) . Only one fragment, UUAGm 1 GCp (MW 1969), was detected for wild-type mt tRNA Leu(CUN) , as expected (left panels in Figure 2D ). In the case of the suppressor tRNA, three species of anticodon-containing fragment, UUAGm 1 GCp (MW 1969), Uτm 5 UAAm 1 GCp (MW 2091) and UUAAm 1 GCp (MW 1953), were clearly detected (right panels in Figure 2D ). Taken together with the nucleoside analysis shown in Figure 2B , this fragment analysis indicates the coexistence of three species of mt tRNAs Figure S1 ).
The G12300A suppressor tRNA Leu(CUN) with partial τm
U modification can decode UUR codons in a mitochondrial translation system
We examined whether the G12300A suppressor mt tRNA Leu(CUN) translates UUR codons as a substitute for the A3243G mutant mt tRNA
, which only poorly decodes the UUA codon and is virtually incapable of decoding the UUG codon (16) . The translational activity of the isolated suppressor tRNA was measured in an in vitro mitochondrial translation system (16, 24) . Human mt tRNAs were purified from the respective cybrid cells and aminoacylated with radioisotope-labeled amino acids. Messenger
RNAs containing 30 repeats of the leucine codons UUA or UUG were transcribed in vitro. As shown in Figure 3 , wild-type mt tRNA Leu(UUR) was efficient in decoding both UUA and UUG codons, whereas wild-type mt tRNA Leu(CUN) could not translate either mRNA. The MELAS A3243G mutant mt tRNA Leu(UUR) lacking the wobble modification showed a substantial reduction in UUA decoding (due to the point mutation) as well as a severe reduction in UUG decoding (due to the modification defect), as reported previously (16) . The G12300A suppressor mt tRNA Leu(CUN) exhibited UUA and UUG decoding activities more efficient than those of the A3243G mutant mt tRNA Leu(UUR) . Considering that the isolated suppressor tRNA consists of three species of mt tRNAs Leu(CUN) , it is most likely that the 29% of the population that has the τm 5 UAA anticodon and the 32% that has the unmodified UAA anticodon can both contribute to UUR codon translation, whereas the 39% of the population of molecules 
Discussion
We here provide evidence that partial modification of the anticodon of the G12300A suppressor tRNA occurs in vivo, enabling it to decode both UUA and UUG codons. Our findings suggest the following scenario to explain the mechanism by which the G12300A mutation suppresses the MELAS A3243G phenotype (Figure 4) . In wild-type mitochondria, mt tRNA
, with anticodon τm 5 UAA, and mt tRNA and mt tRNA Lys , both of which have no G or C in their anticodon, could never decode codons ending in pyrimidine (UUY or AAY, respectively) when lacking wobble modifications (16, 25) .
In the suppressor cybrid cells first isolated (17) , the frequency of the G12300A , is thus the primary cause of the MELAS mitochondrial translation disorder.
Our first concern in studying this suppression mechanism was to determine whether the suppressor mt tRNA Leu , is required for τm 5 U modification. However, in this study we found that the G12300A suppressor mt tRNA Leu(CUN) exhibits only partial τm 5 U modification. Since the primary sequences of the two leucine-specific tRNAs are dissimilar (42% homology) ( Figure   1 ), this finding demonstrates that the adenosine at the anticodon third position (A36) is a determinant for τm 5 U modification of the suppressor mt tRNA Leu(CUN) . However, A36 is clearly not sufficient for modification, since the mutant forms of mt tRNA Leu(UUR) found in patients with MELAS retain A36. Moreover, a set of cryptic determinants for τm 5 U modification must be embedded in the primary sequence and/or structure of mt tRNA Leu(CUN) .
In other words, G36 in wild type mt tRNA Leu(CUN) works as a negative determinant to prevent τm 5 U modification, resulting in an unmodified wobble uridine. In human mitochondria, τm 5 U or τm 5 s 2 U is found in five mt tRNAs that translate Leu(UUR), Trp, Lys, Glu and Gln codons (10) . The A36 residue is not conserved among these tRNAs, and it is difficult to identify common structures or candidate determinants for τm 5 U biogenesis shared by this group. This observation indicates that the individual sequence and features of each mt tRNA define the determinants that are recognized by the RNA-modifying enzyme that generates
If there is only one system for τm 5 U biogenesis in human mitochondria, this implies that a complex system of positive and negative determinants in primary tRNA sequences must confer the necessary specificity.
As emphasized above, the biosynthesis of τm 5 U is not fully understood. We previously reported that free taurine is a direct substrate for the second step of τm 5 U modification (10), but the initial step remains to be ascertained. A series of pathogenic point mutations, as well as the G12300A suppressor mutation, are considered to influence the first step of τm 5 U modification. However, we still need to identify a methyl donor for the C5-methylene group of τm 5 U and its RNA-modifying enzyme(s), in order to understand properly the molecular pathology of the associated diseases. The τm 5 U is classed as an xm 5 U modification, which includes 5-methylaminomethyluridine (mnm 5 U) in bacterial tRNAs and 5-carboxynethylaminomethyluridine (cmnm 5 U) in yeast and nematode mt tRNAs (13) . In E.
coli, mnmE (trmE) and gidA are required for the initial step of mnm 5 U modification (27) (28) (29) .
In both human and yeast, MSS1 and MTO1 were found to be the respective homologs of the bacterial mnmE and gidA genes (30, 31) . Their protein products form heterodimers in mitochondria, and mutations affecting these genes are associated with respiratory defects (32) . These observations suggest that the human MSS1 and MTO1 genes encode enzymes that are responsible for the initial step of τm 5 U modification in mt tRNAs. Development of an in vitro τm 5 U reconstitution system using a recombinant MSS1/MTO1 complex will provide a key to clarify τm 5 U biosynthesis in mt tRNAs associated with mitochondrial diseases.
Materials & Methods
Cybrid cell lines
A549 lung carcinoma cybrid cells containing wild-type mtDNA or mtDNA with the A3243G and G12300A mutations have been described (17) . This study used the G T61 line, in which 99% of mtDNA has the A3243G mutation and 61% has the G12300A mutation (18) . Cybrid cells were cultured in normal medium [Dulbecco's modified Eagle's medium/F-12 (1:1) (Gibco-BRL), 10 % fetal calf serum (FCS)]. The mtDNA mutation profile was repeatedly monitored by PCR analysis as previously described (17) .
Purification of human mitochondrial tRNA Leu(CUN)
A crude RNA fraction was extracted from G T61 cells, and the tRNA fraction was obtained by anion exchange column chromatography using DEAE-Sepharose fast flow with a linear gradient of NaCl (200-500 mM) and MgCl 2 (8-16 mM) in a buffer containing 20 mM HEPES-KOH (pH 7.5). The mt tRNA Leu(CUN) fraction was purified to homogeneity by an improved solid-phase DNA probe method (22) , termed chaplet column chromatography, which employs a synthetic 3´ biotinylated DNA probe complementary to tRNA Leu(CUN) (5´-TACTTTTATTTGGAGTTGCACC-3´). Wild-type mt tRNA Leu(CUN) and mt tRNA Leu(UUR) were purified from total RNA extracted from human placenta as described (16) .
Mutant mt tRNA Leu(UUR) bearing the A3243G mutation was purified from cybrid cells as described (11) .
Sequence determination of wild-type mitochondrial tRNA Leu(CUN)
Purified human mt tRNA Leu(CUN) 
Mass spectrometry
An LCQ ion-trap mass spectrometer (ThermoFinnigan) equipped with an electrospray ionization (ESI) source and HP1100 liquid chromatography system (Agilent) was used to analyze nucleosides and RNA fragments. For nucleoside analysis, purified tRNA (0.04 A 260 unit) was digested into nucleosides at 37 °C for 3 h in a 10 µl reaction mixture containing 20 mM Hepes-KOH (pH 7.5), 10 µg/ml nuclease P 1 and 0.5 units/ml bacterial alkaline phosphatase. The hydrolysates were analyzed by LC/MS as previously described (22) . For RNA fragment analysis, purified tRNA (0.04 A 260 unit) was digested with RNase CL 3 (0.04 units, Boehringer Mannheim) in 20 mM Tris-HCl (pH 7.6) at 37 °C for 3 h and treated with 0.1 N HCl at 0 °C for 3 h to cleave the 2´, 3´ cyclic phosphate, and then analyzed by mass spectrometry as previously described (23) .
In vitro mitochondrial translation
The in vitro translation assay was carried out essentially as described previously (16, 24 Poly(UUA) 30 and Poly(UUG) 30 were synthesized in vitro using T7 RNA polymerase , which was employed to normalize both tRNAs for quantification of anticodon-containing fragments.
The sequences of the respective anticodon fragments are represented at right. The arrowheads indicate RNase CL 3 cleavage sites. In normal cells, mt tRNA Leu(UUR) and tRNA Leu(CUN) decode UUR and CUN codons, respectively (at left). In pathogenic cells with the MELAS A3243G mutation, the severe reduction in decoding activity of the UUG codon is caused by the absence of τm 5 U modification in mt tRNA Leu(UUR) . Revertant cells contain a suppressor mt tRNA Leu(CUN) with the G12300A mutation. The suppressor tRNA with an unmodified wobble uridine translates only the UUA codon, whereas the modified version is the only species capable of decoding the UUG codon due to stabilization of the U:G wobble base pair. The remaining wild-type mt tRNA Leu(CUN) is still responsible for decoding CUN codons (at right).
